Children and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big impact. The U.S. Food and Drug Administration has approved the immunotherapy drug atezolizumab (Tecentriq) for use in patients with advanced alveolar soft part sarcoma (ASPS) that has spread to other parts of… read on > read on >
Keeping allergies and asthma in check in the new year is a resolution worth keeping. With 2023 dawning, the American College of Allergy, Asthma and Immunology offers some suggestions for keeping symptoms under control all year long. “More than 50 million people in the U.S. suffer from allergic conditions,” said allergist Dr. Kathleen May, president… read on > read on >
COVID-19 patients could soon have a new antiviral pill they can take to guard against severe disease. The treatment, called VV116, worked as well as Paxlovid in people who were at high risk of severe disease in a phase 3 trial in China. The trial was a “great success,” study co-author Ren Zhao, a professor… read on > read on >
On Thursday, ZLINE Kitchen and Bath recalled certain models of its gas kitchen ranges because the oven can emit dangerous levels of carbon monoxide while in use, potentially causing serious injury or death. The company said it has received 44 reports of carbon monoxide emission from customers, including three reports of people needing medical attention.… read on > read on >
New Year’s resolutions can be a fickle thing. They are a time-honored way to promise improvements to yourself and your behavior, a “fresh start” to the new year. But if chosen poorly, a resolution also can be a source of anxiety, disappointment and hopelessness. “They tap into the abiding American spirit of relentless self-improvement, and… read on > read on >
FRIDAY, Dec. 30, 2022 (HealthDay News) – The United States could see a huge rise in diabetes among young people over the next several decades, a new modeling study finds. As many as 220,000 young people under the age of 20 could have type 2 diabetes in 2060, which would represent a nearly eight-fold increase,… read on > read on >
The U.S. Food and Drug Administration’s approval process for the controversial Alzheimer’s drug Aduhelm was “rife with irregularities,” despite lingering doubts about the power of the pricey medication to slow the disease down, a Congressional report released Thursday claims. Actions the agency took with Biogen, maker of Aduhelm, “raise serious concerns about FDA’s lapses in… read on > read on >
Adding climate-impact labeling to fast-food menus can have a big effect on whether or not consumers go “green” when eating out, new research suggests. The finding is based on an online survey that asked consumers to order virtual meals after randomly looking over menus that either had some form of climate labeling or none at… read on > read on >
While 8 of 10 mothers breastfeed their newborns for a short time, the number plummets despite recommendations from experts, in part because milk production falls off. Researchers investigating why that happens found that in women who are obese, inflammation may be the culprit. Prior research has shown that when a person is obese, chronic inflammation… read on > read on >
If you struggle with urinary incontinence and worry that diet drinks may make matters worse, new research suggests they may not have a significant effect. “This study is important in that it may guide clinicians counseling women with urinary incontinence to focus more on behavioral modifications, such as total volume intake, rather than on the… read on > read on >
